ACE Reports.
Make a selection below to explore our full database of 12 results matching: "T Gerlinger"
ACE Reports
(12 Reports)
Closed Incision Negative Pressure-Therapy Does Not Decrease Wound Complications following Revision Total Hip Arthroplasty: A Randomized Controlled Trial
Closed Incision Negative Pressure-Therapy Does Not Decrease Wound Complications after Revision THA
Duloxetine Does Not Affect Opioid Use or Outcomes after Primary TKA: A Randomized Controlled Trial
Dilute Betadine Lavage Reduces the Risk of Acute Postoperative Periprosthetic Joint Infection in Aseptic Revision Total Knee and Hip Arthroplasty: A Randomized Controlled Trial.
The Journal of arthroplasty. 2020 ;():. 10.1016/j.arth.2019.09.011
Dilute Betadine Lavage Reduces the Risk of Acute Postoperative Infection in Aseptic Revision Total Knee or Hip Arthroplasty: A Randomized Controlled Trial
Physical Therapy on Postoperative Day 0 Following Total Knee Arthroplasty: A Randomized Controlled Trial of 394 Patients
A Novel, Automated Text-Messaging System Is Effective in Patients Undergoing Total Joint Arthroplasty
J Bone Joint Surg Am. 2019 Jan 16;101(2):145-151. doi: 10.2106/JBJS.17.01505
Continuous Adductor Canal Blocks Provide Superior Ambulation and Pain Control Compared to Epidural Analgesia for Primary Knee Arthroplasty: A Randomized, Controlled Trial
J Arthroplasty. 2018 Apr;33(4):1040-1044
Adductor Canal Blocks Provide Superior Ambulation and Pain Control for Primary Knee Arthroplasty: A Randomized Controlled Trial
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
J Arthroplasty. 2016 Sep;31(9 Suppl):26-30
Oral and Intravenous Tranexamic Acid are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty
A prospective, multi-center, randomised trial to evaluate the efficacy of a cryopneumatic device on total knee arthroplasty recovery
J Bone Joint Surg Br. 2012 Nov;94-B(11 Suppl):153-6. doi: 10.1302/0301-620X.94B11.30832.